Patent ID: 9585558
Date: 2017-03-07
CPC Classifications: A61B,A61K,G01N

Claim:
1. A method for determining whether a subject has Alzheimer's Disease (AD) or is predisposed for developing AD, comprising using a visible near infrared (VNIR) hyperspectral imaging system to obtain a hyperspectral image (HSI) of the retina of the subject over a range of wavelengths to obtain a HSI spectrum and determining whether the spectrum is indicative of the formation of soluble β-amyloid aggregates, wherein the presence of said soluble β-amyloid aggregates indicates the subject has AD or is predisposed for developing AD, wherein the wavelengths used to obtain the HSI spectrum are in the VNIR range, wherein the method is non-invasive and does not comprise administration of dyes for detection of β-amyloid aggregation.